Altimmune (ALT) Operating Leases (2022 - 2025)
Historic Operating Leases for Altimmune (ALT) over the last 4 years, with Q3 2025 value amounting to $1.2 million.
- Altimmune's Operating Leases fell 1691.78% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1691.78%. This contributed to the annual value of $1.4 million for FY2024, which is 70114.29% up from last year.
- Altimmune's Operating Leases amounted to $1.2 million in Q3 2025, which was down 1691.78% from $1.3 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Operating Leases registered a high of $1.5 million during Q2 2024, and its lowest value of $44000.0 during Q1 2024.
- In the last 4 years, Altimmune's Operating Leases had a median value of $1.3 million in 2025 and averaged $1.0 million.
- In the last 5 years, Altimmune's Operating Leases crashed by 7395.83% in 2023 and then soared by 295000.0% in 2025.
- Quarter analysis of 4 years shows Altimmune's Operating Leases stood at $672000.0 in 2022, then crashed by 73.96% to $175000.0 in 2023, then skyrocketed by 701.14% to $1.4 million in 2024, then fell by 13.48% to $1.2 million in 2025.
- Its Operating Leases stands at $1.2 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.3 million for Q1 2025.